RTsafe and DosimETrICA sign a distribution agreement for Italy

12April 2019

Athens, Greece – April 12, 2019 – RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that it has signed DosimETrICA as its exclusive distributor of PseudoPatient™ products for machine QA and patient QA for Italy.

For more than 20 years, DosimETrICA supplies advanced dosimetric tools and provides consulting services, which are primarily focused on radiotherapy. The company’s mission is to facilitate the most appropriate therapy and safest treatment for cancer patients through the distribution of cutting-edge medical technology.

About RTsafe

RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk. For more information, visit


Press Contact:
Tina Miteko
[email protected]

Explore our Products
& Services
  • 29March 2023

    RTsafe to exhibit at ESTRO 2023 in Vienna

    Read More
  • 13February 2023

    RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

    Read More

Request a quote

ΕΣΠΑ Banner